We are live on ! Find out more
GA

Gagnon Advisors Portfolio holdings

AUM $136M
1-Year Est. Return 21.55%
This Fund
S&P 500
This Quarter Est. Return
+13.46%
1 Year Est. Return
+21.55%
3 Year Est. Return
+78.18%
5 Year Est. Return
+93.01%
10 Year Est. Return
+1,298.31%
AUM
$148M
AUM Growth
-$6.27M
Cap. Flow
-$9.94M
Cap. Flow %
-6.71%
Top 10 Hldgs %
60.03%
Holding
32
New
–
Increased
3
Reduced
5
Closed
3

Top Buys

Rank Stock Value
1
CDNA icon
CareDx
CDNA
+$1.52M
2
FIVN icon
FIVE9
FIVN
+$992K

Top Sells

Rank Stock Value
1
ZUO
Zuora, Inc.
ZUO
+$2.97M
2
YEXT icon
Yext
YEXT
+$2.87M
3
HRTX icon
Heron Therapeutics
HRTX
+$2.43M
4
LL
LL Flooring Holdings, Inc.
LL
+$2.13M
5
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
+$1.43M

Sector Composition

Rank Sector Weight
1 Technology 29.39%
2 Healthcare 27%
3 Industrials 18.93%
4 Energy 13.84%
5 Real Estate 3.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APEN
1
DELISTED
Apollo Endosurgery, Inc.
APEN
$13.3M 8.95%
1,329,354
– –
NVGS icon
2
Navigator Holdings
NVGS
$1.37B
$10.9M 7.33%
907,548
– –
AL
3
DELISTED
Air Lease Corp
AL
$10.1M 6.84%
263,700
– –
EPD icon
4
Enterprise Products Partners
EPD
$82.5B
$9.64M 6.51%
399,855
– –
AMRC icon
5
Ameresco
AMRC
$1.09B
$8.3M 5.6%
145,260
– –
NEWR
6
DELISTED
New Relic, Inc.
NEWR
$7.74M 5.22%
137,048
– –
EVA
7
DELISTED
Enviva Inc.
EVA
$7.64M 5.15%
144,140
– –
BL icon
8
BlackLine
BL
$1.8B
$7.36M 4.97%
109,483
– –
PROF
9
Profound Medical
PROF
$263M
$7.06M 4.77%
648,465
– –
PCRX icon
10
Pacira BioSciences
PCRX
$1.06B
$6.96M 4.7%
180,331
– –
FIVN icon
11
FIVE9
FIVN
$2.12B
$6.44M 4.34%
94,852
+15,809
+20% +$992K
ETWO
12
DELISTED
E2open Parent Holdings
ETWO
$6.41M 4.33%
1,092,450
– –
BLFS icon
13
BioLife Solutions
BLFS
$1.55B
$5.55M 3.75%
304,910
– –
YEXT icon
14
Yext
YEXT
$552M
$5.31M 3.58%
812,497
-525,529
-39% -$2.87M
AOSL icon
15
Alpha and Omega Semiconductor
AOSL
$931M
$5.07M 3.42%
177,557
– –
CDNA icon
16
CareDx
CDNA
$1.97B
$5M 3.38%
438,407
+102,303
+30% +$1.52M
EQIX icon
17
Equinix
EQIX
$103B
$4.49M 3.03%
6,861
– –
SCWX
18
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$3.77M 2.55%
590,730
– –
FRSH icon
19
Freshworks
FRSH
$3.11B
$3.48M 2.35%
236,518
– –
EVBG
20
DELISTED
Everbridge, Inc. Common Stock
EVBG
$3.09M 2.08%
104,383
– –
ZUO
21
DELISTED
Zuora, Inc.
ZUO
$2.62M 1.77%
411,281
-419,793
-51% -$2.97M
PSIX
22
Power Solutions International
PSIX
$641M
$1.98M 1.34%
659,680
– –
CNF
23
CNFinance Holdings
CNF
$37.1M
$1.34M 0.91%
78,472
– –
SLGC
24
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$1.29M 0.87%
512,968
-512,968
-50% -$1.43M
MIRO
25
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
$687K 0.46%
229,802
-149,618
-39% -$587K
1
2

Similar funds

WF
Womack Financial Dallas, Texas $136M AUM 19.05% 1-Year Est. Return
MWA
Muirfield Wealth Advisors Charlotte, North Carolina $136M AUM 14.77% 1-Year Est. Return
SSCM
Sovereign's Capital Management Atlanta, Georgia $136M AUM 5.11% 1-Year Est. Return
BDCMI
Black Diamond Capital Management I St. Thomas $136M AUM
WA
WPG Advisers Baltimore, Maryland $136M AUM 24.41% 1-Year Est. Return
LCM
LuminArx Capital Management New York $136M AUM
NVCHI
New Vernon Capital Holdings II Morristown, New Jersey $136M AUM 29.35% 1-Year Est. Return
GPWA
Gaddis Premier Wealth Advisors Durant, Oklahoma $136M AUM

Gagnon Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Gagnon Advisors held 32 positions worth $148M, down 4.1% from $154M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Gagnon Advisors withdrew a net $9.94M in Q4 2022, closing 3 positions and reducing 5 holdings. Its most notable exit was Heron Therapeutics, an estimated $2.43M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Gagnon Advisors added an estimated $1.52M to CareDx.

  • Gagnon Advisors added most to CareDx in Q4 2022, an estimated $1.52M increase.
  • Gagnon Advisors's biggest Q4 2022 reduction was Zuora, Inc., cutting an estimated $2.97M.
  • Gagnon Advisors fully exited Heron Therapeutics in Q4 2022, selling an estimated $2.43M.
  • Gagnon Advisors's ten largest holdings make up 60% of its $148M portfolio in Q4 2022.
  • Gagnon Advisors opened 0 new positions and closed 3 in Q4 2022.
  • Gagnon Advisors's portfolio value fell 4.1% quarter-over-quarter to $148M.

Based on Gagnon Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.